Singapore markets closed

ProPhase Labs, Inc. (PRPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.47+0.21 (+3.35%)
At close: 04:00PM EDT
6.54 +0.07 (+1.08%)
After hours: 06:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.26
Open6.46
Bid6.47 x 1400
Ask5.99 x 100
Day's range6.23 - 6.55
52-week range4.05 - 9.94
Volume15,734
Avg. volume25,667
Market cap116.751M
Beta (5Y monthly)-0.33
PE ratio (TTM)N/A
EPS (TTM)-0.63
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend date24 May 2022
1y target est20.00
  • Insider Monkey

    ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript

    ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript March 15, 2024 ProPhase Labs, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $-0.27. PRPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Noella Alexander-Young: Hello, and good […]

  • GlobeNewswire

    Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)

    NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase Labs Inc. (NASDAQ: PRPH). The update note includes information on the ProPhase’s business model, services, industry, financial results, valuation, and risks. The update note is available here. Highlights from the note include: FY 2023 Financial Results Update: For the fiscal year ending December 31, 2023

  • GlobeNewswire

    ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives

    Nebula Genomics secures major international B2B deal – Additional significant B2B deals in final stages Ahead of schedule, Pharmaloz Manufacturing accelerates capacity expansion – set for rapid revenue and profit growth Completes full transition and right sized operation in Q4 from clinical lab to cutting edge genomics lab Company to hold a conference call Friday March 15, 2024, at 11:00 AM ET Garden City, NY, March 15, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or t